Cognitive Aging and Decline

AMES: A New Dawn in Early Detection of Cognitive Decline

Introducing AMES: A Self-Administered Tool for Early Detection of Cognitive Decline
Published: September 23, 2023 · Last reviewed:
📖370 words⏱2 min read

The Automated Memory and Executive Screening (AMES) tool, introduced by Huang et al. (2023), represents a significant step in identifying early cognitive decline. Designed for use in primary care settings, AMES evaluates cognitive domains such as memory, language, and executive function. This post reviews the study’s findings and the tool’s potential applications.

Background

Key Takeaway: AMES was developed to address the need for accessible cognitive screening tools that individuals can administer themselves. The research evaluated AMES using a sample of 189 participants, including individuals with mild cognitive impairment (MCI) and those with no diagnosed conditions. Its goal was to assess the tool's reliability, validity, and usability in community-based settings.

AMES was developed to address the need for accessible cognitive screening tools that individuals can administer themselves. The research evaluated AMES using a sample of 189 participants, including individuals with mild cognitive impairment (MCI) and those with no diagnosed conditions. Its goal was to assess the tool’s reliability, validity, and usability in community-based settings.

Key Insights

Key Takeaway: Convergent Validity: AMES demonstrated strong agreement with established cognitive scales, confirming its reliability as a screening tool.
Performance Metrics: The tool achieved an area under the curve (AUC) of 0.88 for detecting MCI, with 86% sensitivity and 80% specificity. For subjective cognitive decline (obj-SCD), it showed an AUC of 0.
  • Convergent Validity: AMES demonstrated strong agreement with established cognitive scales, confirming its reliability as a screening tool.
  • Performance Metrics: The tool achieved an area under the curve (AUC) of 0.88 for detecting MCI, with 86% sensitivity and 80% specificity. For subjective cognitive decline (obj-SCD), it showed an AUC of 0.78, with sensitivity at 89% and specificity at 63%.
  • Accessibility and Application: AMES’s self-administered format makes it a promising option for increasing accessibility while reducing the intimidation often associated with cognitive assessments.

Significance

Key Takeaway: The findings highlight AMES as a valuable tool for identifying early cognitive impairments, particularly MCI. Its ability to provide early detection could lead to more timely interventions and improved outcomes for individuals at risk of cognitive decline.

The findings highlight AMES as a valuable tool for identifying early cognitive impairments, particularly MCI. Its ability to provide early detection could lead to more timely interventions and improved outcomes for individuals at risk of cognitive decline. However, the lower specificity for obj-SCD indicates the potential for false positives, which warrants further refinement of the tool to improve accuracy without compromising usability.

Future Directions

Key Takeaway: Future studies should focus on validating AMES in larger and more diverse populations to enhance its generalizability. Additionally, refining the tool's sensitivity and specificity will be crucial for reducing misclassifications. Expanding its applications to different healthcare settings could also support broader adoption and more consistent screening practices.

Future studies should focus on validating AMES in larger and more diverse populations to enhance its generalizability. Additionally, refining the tool’s sensitivity and specificity will be crucial for reducing misclassifications. Expanding its applications to different healthcare settings could also support broader adoption and more consistent screening practices.

Conclusion

Key Takeaway: AMES presents a practical and innovative approach to cognitive screening, combining accessibility with reliable performance metrics. While the study by Huang et al. (2023) highlights its strengths, further research and refinement will be key to ensuring it meets the needs of diverse populations and settings.

AMES presents a practical and innovative approach to cognitive screening, combining accessibility with reliable performance metrics. While the study by Huang et al. (2023) highlights its strengths, further research and refinement will be key to ensuring it meets the needs of diverse populations and settings.

Reference

Key Takeaway:

Huang, L., Mei, Z., Ye, J., & Guo, Q. (2023). AMES: An Automated Self-Administered Scale to Detect Incipient Cognitive Decline in Primary Care Settings. Assessment, 30(7), 2247-2257. https://doi.org/10.1177/10731911221144774

Related Research

Intelligence Research and Cognitive Abilities

The G Factor: What General Intelligence Really Means

In 1904, Charles Spearman noticed something that would reshape the study of intelligence for the next century: children who scored well on one type of…

Apr 10, 2026

People Also Ask

What are the link between physical activity and cognitive health?

Recent research highlights how everyday physical activity can benefit cognitive health. A study by Hakun et al. (2024) examined the short-term effects of regular physical activity on mental processing speed and working memory. Using real-time assessments, the study provides new insights into how light and moderate physical activities can promote brain health in middle-aged adults.

Read more →
What are sensorimotor variability and early cognition?

A recent study by Denisova and Wolpert (2024) investigates how early sensorimotor features relate to cognitive differences in toddlers diagnosed with autism spectrum disorder (ASD). By examining over 1,000 children with varying IQ levels, the researchers reveal how sensorimotor variability impacts behaviors linked to autism, providing valuable insights for individualized interventions.

Read more →
What are distinct genetic and environmental origins of hierarchical cognitive abilities in adult humans?

Understanding how genetic and environmental influences shape cognitive abilities remains a cornerstone of psychological research. Jiang et al. (2024) present an important study that examines these influences through a structured twin-based model. This research provides insight into how basic and higher-order cognitive functions are differentially affected by genetic inheritance and shared experiences.

Read more →
What are shaping hierarchical cognitive abilities?

Recent research by Jiang et al. (2024) sheds light on the distinct genetic and environmental influences shaping hierarchical cognitive abilities in adults. By categorizing cognitive functions into two levels—basic processes and higher-order functions—this study provides valuable insights into how these abilities develop and differ in their origins.

Read more →
Why is background important?

AMES was developed to address the need for accessible cognitive screening tools that individuals can administer themselves. The research evaluated AMES using a sample of 189 participants, including individuals with mild cognitive impairment (MCI) and those with no diagnosed conditions. Its goal was to assess the tool's reliability, validity, and usability in community-based settings.

How does key insights work in practice?

Convergent Validity: AMES demonstrated strong agreement with established cognitive scales, confirming its reliability as a screening tool. Performance Metrics: The tool achieved an area under the curve (AUC) of 0.88 for detecting MCI, with 86% sensitivity and 80% specificity. For subjective cognitive decline (obj-SCD), it showed an AUC of 0.78, with

📋 Cite This Article

Freitas, N. (2023, September 23). AMES: A New Dawn in Early Detection of Cognitive Decline. PsychoLogic. https://www.psychologic.online/2023/09/23/ames-early-cognitive-decline-detection/

Leave a Reply